Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 217  

    Article Cited by others

ORIGINAL ARTICLE

Standard Operating Procedure for In-house Preparation of 131 I-rituximab for Radioimmunotherapy of Non-Hodgkin's Lymphoma

Pickford Matthew D, Turner J Harvey

Year : 2012| Volume: 11| Issue : 3 | Page no: 105-109

   This article has been cited by
 
1 A Pioneer Experience In Malaysia On In-house Radio-labelling of 131I-Rituximab In The Treatment Of Non-Hodgkinæs Lymphoma And A Case Report of High Dose 131I-Rituximab-BEAM Conditioning Autologous Transplant
Jew Win Kuan,Chiong Soon Law,Xiang Qi Wong,Ching Tiong Ko,Zool Hilmi Awang,Lee Ping Chew,Kian Meng Chang
Applied Radiation and Isotopes. 2016;
[Pubmed]  [Google Scholar] [DOI]
2 Standard Operating Procedure for Prospective Individualised Dosimetry for[131]I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma
JHarvey Turner,PhillipeJ Calais
World Journal of Nuclear Medicine. 2012; 11(3): 110
[Pubmed]  [Google Scholar] [DOI]

 

Read this article